Aspire Biopharma Holdings, Inc. (ASBP) NASDAQ
0.21
+0.0151(+7.67%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.21
+0.0151(+7.67%)
Currency In USD
| Market Cap | 7.89M |
| Enterprise Value | 8.27M |
| P/E Ratio | -0.01 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 118.42 |
| Price/Book Ratio | -0.05 |
| Enterprise/Revenue | 179.67 |
| Enterprise/EBITDA | -0.06 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -3,947.25 |
| Operating Margin | -3,120.17 |
| Return On Assets | -18.66 |
| Return On Equity | 2.85 |
| Revenue | 6,202 |
| Revenue/Share | 0 |
| Gross Profit | -116 |
| EBITDA | -19.35M |
| Net Income | -24.48M |
| Diluted EPS | -16.38 |
| Total Cash | 1M |
| Total Cash/Share | 0.67 |
| Total Debt | 1.38M |
| Total Debt/Equity | -0.22 |
| Current Ratio | 0.17 |
| Book Value Per Share | -4.27 |
| 52-Week Change | -99 |
| 52-Week High | 35 |
| 52-Week Low | 0.16 |
| Moving Average 50 Days | 1.09 |
| Moving Average 200 Days | 8.43 |
| Average Volume | 4.8M |
| Shares Outstanding | 3.46M |
| % Held by Institutions | 0.09 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:40 |
| Last Split Date | January 16, 2026 |